01:27 PM EDT, 08/12/2025 (MT Newswires) -- Health care stocks rose Tuesday afternoon, with the NYSE Health Care Index up 0.3% and the Health Care Select Sector SPDR Fund (XLV) adding 0.4%.

The iShares Biotechnology ETF (IBB) climbing 1.2%.

In corporate news, Biogen (BIIB) Chief Executive Chris Viehbacher sees Novo Nordisk's (NVO) study evaluating its weight-loss drug for Alzheimer's disease as an opportunity to potentially create a more potent therapy, Bloomberg reported, citing the CEO. Biogen shares added 1%.